AngioDynamics (NASDAQ: ANGO) announced a worldwide licensing agreement with privately-held EmboMedics Inc., of Minneapolis, Minn., which develops injectable and resorbable ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Management Comments

AngioDynamics (ANGO) Misses Q3 EPS by 4c, Lowers FY15 GuidanceApril 9, 2015 4:04 PM AngioDynamics Re-Entering Embolization MarketApril 9, 2015 4:03 PM AngioDynamics Re-Entering Embolization MarketApril 9, 2015 4:03 PM AngioDynamics Reports 2015 Third Quarter Financial ResultsApril 9, 2015 4:01 PM AngioDynamics Reports 2015 Third Quarter Financial ResultsApril 9, 2015 4:01 PM